Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline

Pain Practice

Volumn 6, Issue 4, 2006, Pages 265-272

  Gore, Mugdha ^a   Dukes, Ellen ^b   Rowbotham, David ^c   Tai, Kei Sing ^a   Leslie, Douglas L ^d  

^a Avalon Health Solutions Inc   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amitriptyline; Contraindications; Drug interactions; Painful neuropathic disorders; U.K.General Practice Research Database; Warnings precautions

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALTRETAMINE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; BACLOFEN; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; DISULFIRAM; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; ETHCHLORVYNOL; METHYLPHENIDATE; NEFOPAM; NEUROLEPTIC AGENT; NITRATE; PROGESTERONE; RITONAVIR; SIBUTRAMINE; SOTALOL; TERFENADINE; TRAMADOL; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; DIABETIC NEUROPATHY; DRUG ALCOHOL INTERACTION; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG USE; FACE PAIN; FEMALE; HEART ARRHYTHMIA; HUMAN; INCIDENCE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PHANTOM PAIN; POSTHERPETIC NEURALGIA; PRESCRIPTION; PREVALENCE; SEX DIFFERENCE; SPINAL PAIN; TRIGEMINUS NEURALGIA; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMITRIPTYLINE; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANTICONVULSANTS; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FACIAL PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PHANTOM LIMB; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 33845527581     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2006.00101.x     Document Type: Article

References (34)

1. Electronic Medicines Compendium (EMC). Available at: http://emc.medicines.org.uk (accessed October 19, 2004).
2. Collins SL, Moore RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage. 2000;20: 449-458.
3. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology. 2000;55: 915-920.
4. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain. 1999;83: 389-400.
5. Watson CPN, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology. 1998;51:1166-1171.
6. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217-227.
7. Max MB. Thirteen consecutive well-designed randomized trials show that anti-depressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum. 1995;4:248-253.
8. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: Diagnosis, mechanisms and treatment recommendations. Arch Neurol. 2003;60:1524-1534.
9. Dworkin R, Nagasako E, Galer B. Assessment of neuropathic pain. Chapter 27. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York: Guilford Press; 2001:519-548.
10. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd ed. Seattle, WA: IASP Press; 1994.
11. Jensen TS. Anticonvulsants in neuropathic pain: Rationale and clinical evidence. Eur J Pain. 2002; 6 (Suppl. A): 61-68.
12. Jackson KC, Onge EL. Antidepressant pharmacotherapy: Considerations for the pain clinician. Pain Prac. 2003;3:135-143.
13. Richelson E. Pharmacology of antidepressants. Mayo Clin Proc. 2001;76:511-527.
14. Ruoff GE. Depression in the patient with chronic pain. J Fam Pract. 1996; 43 (6 Suppl): S25-S33.
15. Cohen LJ. Rational drug use in the treatment of depression. Pharmacother. 1997;17:46-51.
16. Roose SP, Laghrissi TF, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279:287-291.
17. Bingefors K, Isacson D, Knorring LV, Smedby B, Wicknertz K. Antidepressant-treated patients in ambulatory care: Mortality during a nine-year period after first treatment. Br J Psychiatry. 1996;169:647-654.
18. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: A systematic review and meta-analysis: II: Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47:40-50.
19. Thapa PB, Gideon P, Cost TW, Miliam AB, Ray WA. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998;339:875-882.
20. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316:363-369.
21. American Geriatrics Society. The management of persistent pain in older persons: AGS panel on persistent pain in older persons. J Am Geriatr Soc. 2002;50: S205-S224.
22. Gloth FM. Pain management in older adults: Prevention and treatment. J Am Geriatr Soc. 2001;49:188-199.
23. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: Findings from the 1996 Medical Expenditure Panel survey. JAMA. 2001;286:2823-2829.
24. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Inter Med. 1997;157:1531-1536.
25. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004;5:143-149.
26. Meyer-Rosberg K, Kvarnström A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain-a multi-dimensional burden for patients. Eur J Pain. 2001;5:379-389.
27. Lawson DH, Sherman V, Hollowell J. The General Practice Research Database. Q J Med. 1998;91:445-452.
28. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350:1097-1099.
29. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 2000;136:1231-1236.
30. England JD, Gould HJ. Neuropathic pain. In: Pourman R, Harati Y, eds. Neoromuscular Disorders. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001: 147-157.
31. Haythornthwaite JA, Benrud-Larson LM. Psychological aspects of neuropathic pain. Clin J Pain. 2000;16:S101-S105.
32. Hanlon JT, Shimp LA, Semla TP. Recent advances in geriatrics: drug-related problems in the elderly. Ann Pharmacother. 2000;34:360-365.
33. Williams CM. Using medications appropriately in older adults. Am Fam Physician. 2002;66:1917-1924.
34. Luisi AF, Owens NJ, Hume AL. Drugs and the elderly. In: Gallo JJ, Reichel W, eds. Reichels's Care of the Elderly: Clinical Aspects of Aging, 5th ed. Philadelphia, PA: Williams & Wilkins; 1999:59-87.